Concord Medical Services, a Beijing-based network of radiotherapy and diagnostic imaging centers in China, has set its proposed IPO terms to 12 million American depository shares being offered at between $9.50 and $11.50 per share. It plans to trade on the NYSE under ticker symbol CCM, with J.P. Morgan, Morgan Stanley and CICC serving as co-lead underwriters.
Company shareholders include The Carlyle Group (via Carlyle Asia Growth Partners) and Starr Investments.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.